CompanyGraph
Medlive Technology Co. Ltd.
2192 · HKEX · China
Price data from its 1JZ listing on FSX, quoted in EUR
medlive.cnFinancials as of FY2025
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- PositionOperating margin is 30.1%, higher than 95% of its Health Information Services peers (median 3%)
- FinancialsHigh structural barrier to entry
- Interpretations11 currently firing — 11
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
4.29%
Annual Rate
HKD 0.33Paid semi-annual
Payout Ratio
55.6%Sustainable
Payback Period
2.8 yr
Last Ex-Dividend
May 19, 2026
The reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
7.53BHKD960.21M · vs all stocks (USD)
Trailing P/E
15.18xvs Health Information Services peers
Revenue (TTM)
747.33MCNY95.28M · vs all stocks (USD)
Profit Margin
52.06%vs Health Information Services peers
Beta
0.4410xvs all stocks
52-Week Change
-46.48%vs all stocks
Forward Annual Dividend Yield
4.29%vs all stocks
Market Capitalization
7.53BHKD960.21M · vs all stocks (USD)
Enterprise Value
2.65BHKD337.44M · vs all stocks (USD)
Trailing P/E
15.18xvs Health Information Services peers
Forward P/E
11.67xvs Health Information Services peers
Price to Sales (TTM)
9.27xvs Health Information Services peers
Price to Book (MRQ)
1.05xvs Health Information Services peers
Enterprise to Revenue
3.54xvs Health Information Services peers
Enterprise to EBITDA
13.00xvs Health Information Services peers
Profit Margin
52.06%vs Health Information Services peers
Operating Margin
30.09%vs Health Information Services peers
Return on Assets (TTM)
2.04%vs Health Information Services peers
Return on Equity (TTM)
7.11%vs Health Information Services peers
Revenue (TTM)
747.33MCNY95.28M · vs all stocks (USD)
Revenue per Share (TTM)
0.8760CNYUpdated Aug 19, 2026Quarterly Revenue Growth
4.80%vs Health Information Services peers
Gross Profit (TTM)
448.57MCNY57.19M · vs all stocks (USD)
EBITDA (TTM)
370.61MCNY47.25M · vs all stocks (USD)
Net Income (TTM)
389.10MCNY49.61M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
6.30%vs Health Information Services peers
Operating Cash Flow (TTM)
156.57MCNY19.96M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
72.62MCNY9.26M · vs all stocks (USD)
Forward Annual Dividend Rate
0.3258HKDUpdated Aug 19, 2026Forward Annual Dividend Yield
4.29%vs all stocks
Trailing Annual Dividend Rate
0.2906HKDUpdated Aug 19, 2026Trailing Annual Dividend Yield
3.83%vs all stocks
Payout Ratio
55.62%vs Health Information Services peers
Minority Interest (Equity)
63.57MCNYFY2025 · Dec 31, 2025Revenue
642.15MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
256.71MCNYFY2025 · Dec 31, 2025Gross Profit
385.44MCNYFY2025 · Dec 31, 2025Operating Income
172.45MCNY25.57M · vs all stocks (USD)
Pre-tax Income
360.29MCNYFY2025 · Dec 31, 2025Income Tax Expense
12.40MCNYFY2025 · Dec 31, 2025Net Income
347.89MCNYFY2025 · Dec 31, 2025EBIT
360.84MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
370.61MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
217.04MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
177.59MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
552.00KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.4560CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.4538CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
733.22MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
733.22MSharesFY2025 · Dec 31, 2025Minority Interests (P&L)
-13.55MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
96.28MCNYFY2025 · Dec 31, 2025Free Cash Flow
84.81MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
219.78MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
360.29MCNYFY2025 · Dec 31, 2025Stock-based Compensation
2.34MCNYFY2025 · Dec 31, 2025Other Non-cash Items
-185.84MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-80.51MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
0.00CNYFY2025 · Dec 31, 2025Capital Expenditures
-11.46MCNYFY2025 · Dec 31, 2025Net Intangibles (CF)
-1.37MCNYFY2025 · Dec 31, 2025Net Acquisitions
-13.87MCNYFY2025 · Dec 31, 2025Purchase of Investments
-6.06BCNYFY2025 · Dec 31, 2025Sale of Investments
6.07BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-11.45MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-185.56MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-183.99MCNYFY2025 · Dec 31, 2025Shares Outstanding
737.03MSharesUpdated Aug 19, 2026Float Shares
189.70MSharesUpdated Aug 19, 2026% Held by Insiders
74.22%vs all stocks
% Held by Institutions
17.32%vs all stocks
Total Cash (MRQ)
4.34BCNY553.24M · vs all stocks (USD)
Total Cash per Share (MRQ)
5.06CNYUpdated Aug 19, 2026Total Debt (MRQ)
11.76MCNY1.50M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0021xvs Health Information Services peers
Current Ratio (MRQ)
19.09xvs Health Information Services peers
Book Value per Share (MRQ)
7.67CNYUpdated Aug 19, 2026Total Assets
5.16BCNY764.79M · vs all stocks (USD)
Total Current Assets
3.99BCNYFY2025 · Dec 31, 2025Total Liabilities
229.91MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.17BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
20.81MCNYFY2025 · Dec 31, 2025Total Current Liabilities
209.10MCNYFY2025 · Dec 31, 2025Cash
219.78MCNYFY2025 · Dec 31, 2025Cash Equivalents
2.35BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
2.57BCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.15BCNYFY2025 · Dec 31, 2025Accounts Receivable
200.61MCNYFY2025 · Dec 31, 2025Accounts Payable
22.28MCNYFY2025 · Dec 31, 2025Short-term Debt
7.91MCNYFY2025 · Dec 31, 2025Long-term Debt
2.20MCNYFY2025 · Dec 31, 2025Common Stock (Book)
46.00KCNYFY2025 · Dec 31, 2025Retained Earnings
544.88MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
4.93BCNY730.69M · vs all stocks (USD)
52-Week Low
6.31HKDUpdated Aug 19, 202652-Week High
15.30HKDUpdated Aug 19, 202652-Week Change
-46.48%vs all stocks
Beta
0.4410xvs all stocks
50-Day MA
7.38HKDUpdated Aug 19, 2026200-Day MA
8.98HKDUpdated Aug 19, 2026Avg 10-Day Volume
1.21MSharesUpdated Aug 19, 2026Avg 30-Day Volume
1.38MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.5300CNYUpdated Aug 19, 202611 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How does this company use capital?
Cash Backing With Revenue And Income Streaks
Revenue has risen in each of three years, profit in all three, and it holds more cash than debt.
Reads
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Three-Year Positive Free Cash Flow With Elevated ADX Asymmetry And 50w SMA Above 200w SMA
Three years of positive free cash flow, with the 50-week average above the 200-week.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 30.1%, higher than 95% of its Health Information Services peers (median 3%)Significant
Operating margin: 0.30Industry median: 0.03Industry P95: 0.24Peers compared: 33.00
Profit margin is 52.1%, higher than 95% of its Health Information Services peers (median -1.8%)Significant
Profit margin: 0.52Industry median: -0.02Industry P95: 0.38Peers compared: 33.00
Current ratio is 19.09×, higher than 95% of its Health Information Services peers (median 2.31×)Significant
Current ratio: 19.09Industry median: 2.31Industry P95: 8.51Peers compared: 33.00
Debt-to-equity is 0×, lower than 95% of its Health Information Services peers (median 0.15×)Notable
Debt-to-equity: 0.00Industry median: 0.15Industry P5: 0.01Peers compared: 33.00
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 49,606,277.279Operating Cash Flow (USD, TTM): 19,961,148.312
Financial Health
High structural barrier to entryNotable
Barrier to Entry: 0.87
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Companies that share the same coordination system — how they create, deliver, or capture value.
LianLian DigiTech Co., Ltd.
Tier 1FlowRecurring-Revenue Lock-InInterfaceRisk
Montnets Cloud Technology Co., Ltd.
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
Rackspace Technology, Inc.
Tier 1FlowRecurring-Revenue Lock-InProductionInterface
Youon Technology Co., Ltd.
Tier 1FlowRecurring-Revenue Lock-InProductionInterface
Pexip Holding ASA
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
Upbound Group, Inc.
Tier 1FlowRecurring-Revenue Lock-InRiskInterface
Bytes Technology Group Plc
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
Consensus Cloud Solutions, Inc.
Tier 1FlowRecurring-Revenue Lock-InRuleInterface
Phreesia Inc.
Tier 1FlowRecurring-Revenue Lock-InProductionInterface
Omada Health, Inc.
Tier 1FlowRecurring-Revenue Lock-InInterfaceSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Anhui XDLK Microsystems Co., Ltd.
9 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesMinimal Tax and Interest DragCash Backing With Revenue And Income StreaksRevenue Growing With Receivables GrowingOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration
Motomotion China Corp.
9 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash Backing With Revenue And Income StreaksRevenue Growing With Receivables GrowingOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedThree-Year Positive Free Cash Flow With Elevated ADX Asymmetry And 50w SMA Above 200w SMALow-Leverage Liquidity Configuration
Shenzhen Yanmade Technology Co., Ltd.
8 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesMinimal Tax and Interest DragCash Backing With Revenue And Income StreaksRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration